Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pluristem Announces Significant New Finding From Its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months
Pluristem Announces Significant New Finding From Its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months
Pluristem Announces Significant New Finding From Its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months
Submitted by
admin
on February 2, 2015 - 7:48am
Source:
Yahoo
News Tags:
Pluristem
PLX-PAD
hip arthroplasty
Headline:
Pluristem Announces Significant New Finding From Its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months
Do Not Allow Advertisers to Use My Personal information
